Journal of cancer research and clinical oncology · 2026
Profiling and functional analysis of exosomal circRNAs from EBV-associated gastric carcinoma CSCs.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gong Li-Ping, Shao Yi-Ting, Du Yu, Sun Li-Ping, Tang Lu-Ying, Chen Jian-Ning
Аннотация
BACKGROUND: Recent studies have found that Epstein-Barr virus (EBV) encodes circular RNAs (ebv-circRNAs) that are involved in tumorigenesis process in EBV-associated gastric carcinoma (EBVaGC). Since little is known whether circRNAs can be enriched into exosomes and their functions in EBVaGC cancer stem cells (CSCs). METHODS: Exosomes from EBVaGC CSCs were isolated according to differential ultracentrifugation method. Expression patterns of ebv-circRNAs and human circRNAs in exosomes of EBVaGC CSCs were analyzed by RNA sequencing. CCK-8 assay, wound healing assay, transwell assay and apoptosis analysis were performed to explore the function of exosomes in EBVaGC CSCs. Data differences between two groups were evaluated using Student's t-test and survival analysis was performed by Kaplan–Meier methodology. RESULTS: Two circRNAs, ebv-circLMP2A and hsa-circRNF13 were enriched in EBVaGC CSCs derived exosomes, and positively associated with EBVaGC patients with metastasis. Bioinformatics analysis predicted that miR-5683 is the most likely potential target for both ebv-circLMP2A and hsa-circRNF13, and lower miR-5683 expression was positively correlated with microvessel density and Ki67 expression in clinical samples of EBVaGC. Cytology experiments preliminarily showed that EBVaGC CSCs derived exosomes significantly promoted the invasive growth of EBVaGC cells. CONCLUSIONS: Our findings suggest that exosomal circRNAs could be apromising diagnostic and therapeutic target for EBVaGC.